October 30 - 31, 2018
NIH Pathways to Prevention Workshop: Appropriate Use of Drug Therapies for Osteoporotic Fracture Prevention
About the Workshop
More than 10 million people in the United States have osteoporosis, a skeletal disorder that causes bones to become weak and fragile as a result of low bone mass. The condition makes people more susceptible to fractures, which can impair their ability to live independently and even threaten their lives. Lifestyle changes and medications can help reduce a person's risk of osteoporotic fractures. Bisphosphonates, a first-line pharmacological treatment for most people with osteoporosis, have been found effective with short-term use among individuals who have a high risk of fracture; however, the benefits and risks of longer-term treatment are less clear.
The National Institutes of Health (NIH) is hosting the Pathways to Prevention Workshop on Appropriate Use of Drug Therapies for Osteoporotic Fracture Prevention to better understand current knowledge gaps and to identify future research needs in using osteoporosis drugs.
The workshop is free and open to the public—including patients, patient advocates, and their families, and is designed for researchers, practitioners, and other professionals who are interested in fracture prevention and the use of osteoporosis drugs. Registration is required, and attendees can join either in person or via NIH VideoCast (in-person attendance is strongly encouraged).
This event does not offer CME.
Natcher Conference Center (Building 45)
NIH Main CampusBethesda, Maryland
NIH Office of Disease Prevention
National Institutes of Health Office of Disease Prevention